Abrilumab
Abituzumab
Caplacizumab
Veltuzumab
Efalizumab
Etrolizumab
RGD-4C
Enlimomab
Volociximab
Etaracizumab
Ontamalimab
Bersanlimab
Tadocizumab
Rovelizumab
Cyclo(Ala-Arg-Gly-Asp-Mamb)
BT200 sodium
RTDLDSLRTYTL
ATN-161
GSK 3008348 hydrochloride
Fradafiban